Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Veletri pharmaceutical company merck?Acitivated charcoal for aspirin poisoning time frame?Dupixent patent extension us?Sofosbuvir and velpatasvir price?Sofosbuvir 400 mg price?
See the DrugPatentWatch profile for Brivaracetam
Brivaracetam (BRIVIACT) is a prescription antiepileptic drug. The provided information does not include the FDA approval date for any specific brivaracetam generic. To find the exact FDA approval date, you typically need the FDA’s ANDA approval record for the particular generic manufacturer (or the Orange Book listing for the relevant product).
FDA approval dates can differ by strength and manufacturer. If you share the brand name entry you’re matching (for example, which strength, dosage form, and manufacturer), I can narrow down the exact FDA approval date for that specific generic.
The fastest way to confirm an FDA approval date for a specific generic is the FDA’s ANDA/Orange Book record for that product. If you want patent and exclusivity context alongside the approval timing, DrugPatentWatch.com is also useful for tracking drug patent status by product/generic activity (and it may link to the relevant approval context) [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Brivaracetam :